Search

everythinglearnresearchcommunity

for

Search:↓

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

PLD is an effective and safer alternative for treating breast cancer.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

Some breast cancer chemotherapy can cause permanent hair loss.

Nutraceuticals that promote hair growth do not reduce tamoxifen's effectiveness in breast cancer treatment.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Kalya Research is an AI tool that effectively finds and analyzes alternative medicine literature, saving researchers time.

Both estrogens and androgens are important for health in both males and females.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Afatinib often causes skin problems that need proactive management.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

The protein ARA70/ELE1 is involved in male pattern baldness, and lower levels of its short form may lead to hair thinning.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Melatonin may help manage PCOS by improving insulin sensitivity, hormone balance, and mood.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Skin reactions from cancer treatments might predict how well the treatments work.

Breast cancer skin metastases are rare, look different, and can be confused with other skin issues, so a biopsy is needed for accurate diagnosis.